Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total
Beginning Balance, Shares at Mar. 31, 2019	20,765,592
Beginning Balance, Amount at Mar. 31, 2019	$ 20,766	$ 15,971,905	$ (13,425,879)	$ (339,888)	$ 2,226,904
Issuance of common shares, net of offering costs, Shares	14,338
Issuance of common shares, net of offering costs, Amount	$ 14	142,903			142,917
Restricted shares issued as stock- based compensation to consultants and investor relations, Shares	25,500
Restricted shares issued as stock- based compensation to consultants and investor relations, Amount	$ 25	231,924			231,949
Exercise of warrants, Shares	2,500
Exercise of warrants, Amount	$ 3	25,997			26,000
Reverse split adjustment, Shares	418
Reverse split adjustment, Amount
Foreign currency translation adjustment				(48,986)	(48,986)
Net loss			(2,813,312)		(2,813,312)
Ending Balance, Shares at Dec. 31, 2019	20,808,348
Ending Balance, Amount at Dec. 31, 2019	$ 20,808	16,372,729	(16,239,191)	(388,874)	(234,528)
Beginning Balance, Shares at Sep. 30, 2019	20,802,930
Beginning Balance, Amount at Sep. 30, 2019	$ 20,803	16,332,734	(15,794,184)	(363,040)	196,313
Restricted shares issued as stock- based compensation to consultants and investor relations, Shares	5,000
Restricted shares issued as stock- based compensation to consultants and investor relations, Amount	$ 5	39,995			40,000
Reverse split adjustment, Shares	418
Reverse split adjustment, Amount
Foreign currency translation adjustment				(25,834)	(25,834)
Net loss			(445,007)		(445,007)
Ending Balance, Shares at Dec. 31, 2019	20,808,348
Ending Balance, Amount at Dec. 31, 2019	$ 20,808	16,372,729	(16,239,191)	(388,874)	(234,528)
Beginning Balance, Shares at Mar. 31, 2020	20,850,848
Beginning Balance, Amount at Mar. 31, 2020	$ 20,851	16,589,272	(17,586,075)	(336,992)	(1,312,944)
Issuance of common shares, net of offering costs, Shares	1,994,924
Issuance of common shares, net of offering costs, Amount	$ 1,995	14,791,484			14,793,479
Restricted shares issued as stock- based compensation to consultants and investor relations, Shares	46,702
Restricted shares issued as stock- based compensation to consultants and investor relations, Amount	$ 47	223,153			223,200
Exercise of warrants, Shares	37,933
Exercise of warrants, Amount	$ 38	394,437			394,475
Foreign currency translation adjustment				356,765	356,765
Net loss			(4,127,970)		(4,127,970)
Ending Balance, Shares at Dec. 31, 2020	22,930,407
Ending Balance, Amount at Dec. 31, 2020	$ 22,931	31,998,346	(21,714,045)	19,773	10,327,005
Beginning Balance, Shares at Sep. 30, 2020	22,893,705
Beginning Balance, Amount at Sep. 30, 2020	$ 22,894	31,838,383	(20,267,348)	(351,502)	11,242,427
Restricted shares issued as stock- based compensation to consultants and investor relations, Shares	36,702
Restricted shares issued as stock- based compensation to consultants and investor relations, Amount	$ 37	159,963			160,000
Foreign currency translation adjustment				371,275	371,275
Net loss			(1,446,697)		(1,446,697)
Ending Balance, Shares at Dec. 31, 2020	22,930,407
Ending Balance, Amount at Dec. 31, 2020	$ 22,931	$ 31,998,346	$ (21,714,045)	$ 19,773	$ 10,327,005